Non-cystic Fibrosis and Non-tuberculosis Sequela Bronchiectasis

Non-cystic fibrosis and non-tuberculous bronchiectasis are being increasingly recognized as a result of improved imaging techniques, particularly high-resolution computed tomography, which remains the diagnostic gold standard, and greater clinical awareness. The disease encompasses a broad spectrum of etiologies, leading to marked heterogeneity in clinical presentation, severity, and progression. Understanding the underlying cause is essential, as it directly influences prognosis and therapeutic decision-making. Medical management represents the cornerstone of treatment and should be individualized according to disease etiology and severity. Core strategies include airway clearance techniques, long-term antibiotic therapy, and optimized management of associated comorbidities.